29 Amendments of Pernille WEISS related to 2023/2075(INI)
Amendment 26 #
Motion for a resolution
Citation 7 a (new)
Citation 7 a (new)
– having regard to the EU Action Plan on Childhood Obesity 2014-2020,
Amendment 39 #
Motion for a resolution
Citation 9 a (new)
Citation 9 a (new)
– having regard to the World Health Organization 'Health service delivery framework for prevention and management of obesity' (2023),
Amendment 40 #
Motion for a resolution
Citation 9 b (new)
Citation 9 b (new)
– having regard to the World Health Organization 'Acceleration plan to support Member States in implementing the recommendations for the prevention and management of obesity over the life course' (2022),
Amendment 66 #
Motion for a resolution
Recital B
Recital B
B. whereas premature deaths as a result of cardiovascular diseases (CVDs), cancers, diabetes and chronic respiratory diseases account for 68 % of all premature deaths in Europe; whereas other NCDs include mental and neurological disorders, kidney diseases, liver diseases, oral diseases, osteoporosis, osteoarthritis and endometriosis among other conditions;
Amendment 70 #
Motion for a resolution
Recital B a (new)
Recital B a (new)
Ba. whereas obesity is the fourth largest cause of premature deaths globally with an estimated 4.7 million deaths1a; whereas there are over 200 medical complications of obesity; _________________ 1a GBD 2017 Risk Factor Collaborators – “Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017”
Amendment 75 #
Motion for a resolution
Recital C
Recital C
C. whereas NCDs account for the largest share of countries’ healthcare expenditures, costing EU economies and are predicted to lead to the forfeiture of potential productive years among workers afflicted by such conditions1b, estimated in 2016 to a cost of EUR 115 billion, or 0.8 % of GDP annually as well as entailing other societal costs such as loss of productivity and workforce; whereas in 2018, no more than 2.8 % of total health expenditure in the EU was spent on prevention, whereas the costs of treating NCDs remains high5 ; _________________ 1b OECD, 'Health at a Glance: Europe, 2016', p. 3, December 2016 5 European Commission, ‘Healthier together – EU non-communicable diseases initiative’, p. 15, June 2022.
Amendment 84 #
Motion for a resolution
Recital D
Recital D
D. whereas theNCDs constitute an increasing burden on patients, families, carers, the labour market and wider society; whereas in addition to the individual impact, the burden of NCDs and the health needs of ageing populations represent challenges to the health systems of the Member States;
Amendment 106 #
Motion for a resolution
Recital E
Recital E
E. whereas most NCDs are impacted by four preventable risk factors:, including their interplay: Notably tobacco use, unhealthy diet, lack of physical activity and harmful use of alcohol; whereas behavioural risk factors may lead to biological risk factors, the most common being overweight and obesity, high blood pressure, high blood glucose and high blood cholesterol6 ; _________________ 6 World Health Organization, ‘Monitoring noncommunicable disease commitments in Europe 2021’, p. 13, 8 December 2021.
Amendment 227 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Welcomes the Healthier together – EU non-communicable diseases (NCD) initiative, Europe’s Beating Cancer Plan, EU4Health work programme and the Commission Communication entitled ‘A comprehensive approach to mental health’; calls on the Commission to strengthen the ‘Healthier together – EU NCD’ initiative by introducing a holistic EU strategy on NCDs complemented by action plans for specific NCDs, including obesity; welcomes national plans and actions already taken against NCDs by Member States and calls in this regard for sharing of best practice between Member States;
Amendment 236 #
Motion for a resolution
Paragraph 2 a (new)
Paragraph 2 a (new)
2a. Calls on every Member State to develop national NCD plans to complement the ‘Healthier together – EU non-communicable diseases (NCD)’ initiative; asks Member States to include in their national plans ambitious measures to address all stages of NCDs, from early detection to disease management, and to tailor these national plans to specific NCDs;
Amendment 243 #
Motion for a resolution
Paragraph 2 b (new)
Paragraph 2 b (new)
2b. Calls on the Commission to facilitate the sharing and scale-up of best practices between Member States with regard to national plans and other actions already taken against NCDs at the Member State level; invites Member States to implement clear and comparable targets, benchmarks and indicators in their NCD national plans to monitor and compare progress;
Amendment 244 #
Motion for a resolution
Paragraph 2 c (new)
Paragraph 2 c (new)
2c. Building on the experiences of the Knowledge Centre on Cancer, calls on the Commission to create a Knowledge Centre on Obesity to gather data, share best practices and prepare the way for implementation of an NCD framework for obesity along the life course;
Amendment 397 #
Motion for a resolution
Paragraph 8 – introductory part
Paragraph 8 – introductory part
8. Notes that an unhealthy diet is one of the major risk factors forobesity acts as a gateway disease to many NCDs, including cardiovascular diseases, cancer, diabetes and other conditions linked to obesity15 ; acknowledges that obesity is considered a risk factor for several NCDs; calls on the Commission and the Member States to: and is in itself a recognized chronic relapsing NCD; _________________ 15 World Health Organization Regional Office for the Eastern Mediterranean, ‘Noncommunicable diseases’.
Amendment 404 #
Motion for a resolution
Paragraph 8 – point a
Paragraph 8 – point a
a. encourage and help consumers to make informed and healthy choices about food products; promote behavioural changes via communication and mass media campaigns for healthy diets; encourage public food procurement and service policies for healthy and sustainable dieCalls on the Member States to consider the use of food labelling to inform consumers about food products;
Amendment 412 #
Motion for a resolution
Paragraph 8 – point a a (new)
Paragraph 8 – point a a (new)
aa. Calls on the Member States to promote behavioural changes via communication and mass media campaigns based on scientific evidence;
Amendment 414 #
Motion for a resolution
Paragraph 8 – point a b (new)
Paragraph 8 – point a b (new)
ab. Calls on the Member States to consider applying differentiated VAT, in line with the options of the EU VAT Directive, to encourage the uptake of certain foods;
Amendment 425 #
b. Calls on the Commission to propose a New Action Plan for child obesity, including measures and recommendations for early diagnosis and screening, treatment and long term management, which addresses also the impact of parental obesity and the demand for interdisciplinary treatment and management services;
Amendment 436 #
Motion for a resolution
Paragraph 8 – point b a (new)
Paragraph 8 – point b a (new)
ba. Calls on the Commission to include obesity as a chronic relapsing disease in future revisions of the EU NCD Initiative;
Amendment 461 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Highlights the role of physical activity in NCD prevention in health promotion at population level for all major chronic diseases and welcomes Commission’s HealthLifestyle4All initiative; calls on the Commission and Member States to promote physical activity and awareness campaigns to prevent NCDs;
Amendment 501 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Stresses that per- and polyfluorinated alkyl substances (PFAS) can lead to health problemserious medical conditions such as obesity and cancer16 ; calls on the Commission to implement the PFAS restriction proposal submitted to European Chemicals Agency on 13 January 202317 ; _________________ 16 European Environment Agency, ‘What are PFAS and how are they dangerous for my health?’. 17 European Chemicals Agency, ‘ECHA publishes PFAS restriction proposal’, 2023.
Amendment 534 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Encourages the Commission and the Member States to achieve the UN Sustainable Development Goals that target communicable diseases in order to promote the prevention of NCDs such as cancer related to infectious diseases; welcomes vaccination programmes in this regard such as in the fight against human papillomavirus transmission; calls on Member States to consider introducing gender-neutral HPV vaccinations in their vaccination programmes;
Amendment 596 #
Motion for a resolution
Paragraph 17
Paragraph 17
17. Notes that some NCDs are closely linked such as diabettype 2 diabetes, obesity, oral diseases and cardiovascular diseases and that important synergies can be achieved by improving diagnosis and integrated care19 ; _________________ 19 European Commission, ‘Healthier together – EU non-communicable diseases initiative’, p. 30, June 2022.
Amendment 618 #
Motion for a resolution
Paragraph 18
Paragraph 18
18. Stresses that nurses, doctors, general practitioners, oral health professionals, pharmacists, dieticians and other primaryhealth care professionals have a significant role in referring patients for diagnostic tests and treating NCDs; encourages the Member States to offerprioritise inter-professional training and upskilling, including training to healthcare professionals to better identify high-risk individuals as well as prevent and treat NCDs;
Amendment 651 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Believes that every patient is different and no NCD is the same; calls for NCDs to be prevented and treated as effectively as possible, with a personalised approach tailored to the patient and the disease; calls on Member States to prioritize also training of health care professionals which enable them to support patients in engaging in their own treatment and in improving therapeutic adherence;
Amendment 707 #
Motion for a resolution
Paragraph 20
Paragraph 20
20. Recalls that patient empowerment and health literacy are, in view of enabling improved treatment adherence and health literacy among different groups of society, is crucial for an EU NCD strategy and that treatment and care should be patient-centred; encourages the promotion of well-informed patients who are actively involved in their own treatment and calls for the therapeutic training of caregivers and patients and their empowerment in the care programmes;
Amendment 730 #
Motion for a resolution
Paragraph 22
Paragraph 22
22. Welcomes the pharmaceutical package of April 26 2023, and calls for the strengthening of the European medicines market to ensure access to medicines and alleviate medicine shortages, reduce barriers to cross-border business, while strengthening incentives for investment in innovation; underlines that regulatory data protection and intellectual property rights are crucial to ensure competitiveness in the EU by incentivising innovators to develop new products and further ongoing research efforts; recalls that any reduction in the baseline protection of regulatory data protection risks undermining investments in innovative treatments, including those targeting NCDs;
Amendment 767 #
Motion for a resolution
Paragraph 24
Paragraph 24
24. Calls on the Commission to strengthen support and investment in the development of new innovative medical devices and medicinal products; believes that new technologies can lead to new and better treatments for NCDs; calls on the Member States to continually invest in innovation for addressing NCDs; underlines the importance in this regard of EU funding such as the EU4Health and Horizon Europe programmes;
Amendment 781 #
Motion for a resolution
Paragraph 24 a (new)
Paragraph 24 a (new)
24a. Calls on Member States to take actions to improve adherence to treatment in order to secure greater health benefits from investments into treatments of NCDs;
Amendment 787 #
Motion for a resolution
Paragraph 25
Paragraph 25
25. Believes that improving knowledge and sharing of evidence-based best practices among Member States is needed to accelerate effective prevention measures and innovative practices, including digital solutions; recalls that the implementation of the European Health Data Space should contribute to strengthening the underlying data for evidence-based public health policy;